Health ❯Medicine ❯Pharmaceuticals

Drug Approval

FDA Advisory Committee Chronic Obstructive Pulmonary Disease Obstructive Sleep Apnea Zepbound FDA Regulations Alzheimer's Disease FDA Novel Medicine Iloprost Alzheimer's Treatment

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

It will be available only to early-stage patients with zero or one ApoE4 allele in a controlled access program pending European Commission approval.

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

FDA Approves Regeneron-Sanofi's Dupixent for COPD Treatment

FDA Approves First-Ever Drug to Treat Severe Frostbite

FDA Approves AstraZeneca and Ionis' Wainua for Rare Nerve Disease

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies